Items Per Page 102550 Year All202420232022202120202019201820172016 03/28/2024 Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results 03/25/2024 Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection 03/21/2024 Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human 02/13/2024 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 01/04/2024 Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook